Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATCH: Pirfenidone in Chronic Pancreatitis
NCT07755813Phase 2Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Aug 2030
01
Overview
Phase 2, randomised, double-blind trial in chronic pancreatitis (CP) comparing Pirfenidone with Placebo (2 arms). Primary endpoint: Number of Participants With at Least One Grade 3 or Grade 4 Adverse Event at 48 weeks. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
pirfenidone
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT07755813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755813.